Pfizer reports loss as it eyes big oncology push
Pfizer reported a quarterly loss Tuesday on much lower sales of COVID-19 products as it emphasized progress on cost-cutting and drug development initiatives.
Jan 30, 2024
0
1
Pfizer reported a quarterly loss Tuesday on much lower sales of COVID-19 products as it emphasized progress on cost-cutting and drug development initiatives.
Jan 30, 2024
0
1
The announcement that King Charles III was admitted to a private hospital Friday to undergo a procedure for an enlarged prostate has sparked interest in what is an extremely common condition among older men.
Jan 26, 2024
0
1
Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, only about 1 in 44 will die from it. Most men diagnosed with prostate cancer die from other causes, especially those with ...
Jan 26, 2024
0
1
A lack of cancer progression could be used as a substitute for overall survival in metastatic hormone-sensitive prostate cancer clinical trials, according to a new meta-analysis published in the Journal of Clinical Oncology, ...
Jan 26, 2024
0
0
Just by looking at a short portion of a man's genome it is possible to estimate the probability that he will die from prostate cancer—even before he has the cancer—thanks to a massive genetic study by RIKEN researchers. ...
Jan 25, 2024
0
53
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos Vargas, a Mayo Clinic radiation ...
Jan 25, 2024
0
1
Experiments with rats conducted by researchers at São Paulo State University (UNESP) in Brazil increase our understanding of why descendants of women who were malnourished during pregnancy tend to face a higher risk of prostate ...
Jan 24, 2024
0
51
According to the Centers for Disease Control and Prevention, cancer is a leading cause of death in the United States. Unfortunately for American men, prostate cancer remains one of the deadliest cancers.
Jan 24, 2024
0
0
Combining testosterone-blocking drugs in patients with prostate cancer relapse prevents the spread of cancer better than treatment with a single drug, a multi-institution, Phase 3 clinical trial led by UC San Francisco researchers ...
Jan 23, 2024
0
3
Human pathologists are extensively trained to detect when tissue samples from one patient mistakenly end up on another patient's microscope slides (a problem known as tissue contamination). But such contamination can easily ...
Jan 23, 2024
0
0